FREE LIVE WEBINAR

April 10th | 12 PM to 1:30 PM ET

FDA disruption: mitigating risk in an unstable U.S. regulatory environment

The recent layoffs at the FDA have sent ripples throughout the medical device industry, raising critical questions about regulatory timelines, submission backlogs, and the future of device innovation. As the industry adapts to these changes, medical device professionals must understand how to navigate the evolving regulatory landscape and mitigate potential risks to their product development strategies.

Join us for this timely and insightful webinar where our expert panel will unpack the implications of the FDA workforce reduction and provide actionable guidance to help you stay ahead.

• Discussion of the potential impact on regulatory timelines, submission reviews, and market approvals for medical devices.

• Explore how companies can proactively manage risks and adjust regulatory strategies in response to delayed reviews or reduced communication from the FDA.

• Gain insights into how industry leaders are responding to the changes and what this could mean for innovation and product launches in 2025 and beyond.

• Learn best practices for maintaining compliance and forward momentum amid regulatory uncertainty.